Burr D B, Yoshikawa T, Teegarden D, Lyle R, McCabe G, McCabe L D, Weaver C M
Department of Anatomy and Cell Biology, Department of Orthopedic Surgery, and Biomechanics and Biomaterials Research Center, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Bone. 2000 Dec;27(6):855-63. doi: 10.1016/s8756-3282(00)00403-8.
Women who exercise during their second and third decades may increase their peak bone mass and lower their eventual risk for postmenopausal fracture. However, the effects of exercise in younger women can be modulated by the use of oral contraceptives, which may prevent the normal accretion of bone mass that would otherwise occur. We hypothesized that exercise intervention in young adult women would significantly increase both bone mass and the bending rigidity of the femoral neck. We further hypothesized that exercise intervention in the presence of oral contraceptive use would have a negative effect on bone mass and bending rigidity. Women 18-31 years of age (n = 123) were classified by oral contraceptive use (OC, NOC) and age (18-23, 24-31 years), and then randomized into exercise or nonexercise groups. The exercise protocol consisted of three sessions/week of aerobic and nonaerobic exercises, and continued for 2 years. Each 6 months, the femoral neck of each subject was scanned using a Lunar dual-energy X-ray absorptiometry (DEXA) scanner, and bone mineral content, density and geometric information were used to calculate estimated stresses and bending rigidity at the hip. Percent changes from baseline were analyzed using two-way analysis of variance (ANOVA) at 6, 12, 18, and 24 months. Women who neither exercised nor took oral contraceptives (NE/NOC) had the greatest percentage increases in cross-sectional area (4.98 +/- 2.29%), cross-sectional moment of inertia (9.45 +/- 2.37%), total bone mineral density (2.07 +/- 2.09%), fracture index (8.03 +/- 2.03%), and safety factor (20.03 +/- 5.79%) over the 24 month exercise program. Women who exercised and did not take oral contraceptives (E/NOC) declined on most variables related to femoral strength and bone mass, whereas those women who took oral contraceptives were usually intermediate between NE/NOC and E/NOC, whether they exercised or not. These data show that either exercise or OC use is associated with a suppression of the normal increase in bone mass and mechanical strength in the femoral neck in women 18-31 years old, but the combination of exercise and OC use appears to have a less suppressive effect.
在二三十岁时进行锻炼的女性可能会增加其峰值骨量,并降低绝经后骨折的最终风险。然而,年轻女性锻炼的效果可能会受到口服避孕药使用的调节,口服避孕药可能会阻止原本会发生的正常骨量增加。我们假设,对年轻成年女性进行运动干预会显著增加骨量和股骨颈的抗弯刚度。我们进一步假设,在使用口服避孕药的情况下进行运动干预会对骨量和抗弯刚度产生负面影响。将18至31岁的女性(n = 123)按口服避孕药使用情况(使用避孕药组、未使用避孕药组)和年龄(18 - 23岁、24 - 31岁)进行分类,然后随机分为运动组或非运动组。运动方案包括每周三次有氧运动和无氧运动,并持续2年。每6个月,使用Lunar双能X线吸收仪(DEXA)扫描仪对每个受试者的股骨颈进行扫描,并使用骨矿物质含量、密度和几何信息来计算髋部的估计应力和抗弯刚度。在6、12、18和24个月时,使用双向方差分析(ANOVA)分析相对于基线的百分比变化。在为期24个月的运动计划中,既不锻炼也不服用口服避孕药的女性(未锻炼/未使用避孕药组)在横截面积(4.98 +/- 2.29%)、截面惯性矩(9.45 +/- 2.37%)、总骨矿物质密度(2.07 +/- 2.09%)、骨折指数(8.03 +/- 2.03%)和安全系数(20.03 +/- 5.79%)方面的百分比增加最大。进行锻炼但不服用口服避孕药的女性(锻炼/未使用避孕药组)在与股骨强度和骨量相关的大多数变量上有所下降,而那些服用口服避孕药的女性,无论是否锻炼,通常处于未锻炼/未使用避孕药组和锻炼/未使用避孕药组之间。这些数据表明,锻炼或口服避孕药的使用都与18至31岁女性股骨颈骨量和机械强度的正常增加受到抑制有关,但锻炼和口服避孕药联合使用似乎具有较小的抑制作用。